Cardiac Resynchronization Therapy: Who Benefits?

Código QR

Cardiac Resynchronization Therapy: Who Benefits?

Background: Cardiac resynchronization therapy (CRT) has been well established in multiple large trials to improve symptoms, hospitalizations, reverse remodeling, and mortality in well-selected patients with heart failure when used in addition to optimal medical therapy. Updated consensus guidelines...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jason S. Chinitz, Andre d'Avila, Martin Goldman, Vivek Reddy, Srinivas Dukkipati
Formato:	article
Lenguaje:	EN
Publicado:	Ubiquity Press 2014
Materias:	biventricular pacing cardiac resynchronization therapy cardiomyopathy dyssynchrony heart failure implantable cardioverter defibrillator Infectious and parasitic diseases RC109-216 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/431a71bf02084a4398874f3e3de0b6df
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cardiac resynchronization therapy pacemaker: critical appraisal of the adaptive CRT-P device
por: Daoud GE, et al.
Publicado: (2016)

Evaluation of potential underuse of cardiac resynchronization therapy for heart failure with reduced ejection fraction
por: Makoto Takano, et al.
Publicado: (2021)

Evolución clínica y ecográfica posterior a terapia de resincronización cardíaca
por: Flores,Pablo, et al.
Publicado: (2016)

Very Long-Term Follow-Up in Cardiac Resynchronization Therapy: Wider Paced QRS Equals Worse Prognosis
por: Patrick Leitz, et al.
Publicado: (2021)

Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting
por: Christian Blockhaus, et al.
Publicado: (2021)

A successful placement of the left ventricular lead for the cardiac resynchronization device using the orthodromic snare technique: clinical case
por: Oleg L. Dubrovin, et al.
Publicado: (2021)

Cardiac Electronic Devices: Future Directions and Challenges
por: Kotalczyk A, et al.
Publicado: (2020)

Terapia de resincronización en pacientes con insuficiencia cardiaca: experiencia acumulada de 10 años
por: Enríquez,Andrés, et al.
Publicado: (2013)

Balloon angioplasty of cardiac vein in a patient treated by cardiac resynchronization therapy
por: Đurić Predrag, et al.
Publicado: (2021)

Right Ventricular Endocardial Mapping and a Potential Arrhythmogenic Substrate in Cardiac Amyloidosis—Role of ICD
por: Aleksandra Liżewska-Springer, et al.
Publicado: (2021)

Modified frailty as a novel factor in predicting the response to cardiac resynchronization in the elderly population
por: Mlynarska A, et al.
Publicado: (2019)

Wearable Cardioverter–Defibrillator-Measured Step Count for the Surveillance of Physical Fitness during Cardiac Rehabilitation
por: Boldizsar Kovacs, et al.
Publicado: (2021)

Implantable cardioverter defibrillators: Uses, abuses, gains and complications
por: Weiwei Li, et al.
Publicado: (2017)

A case of pacing-induced cardiomyopathy dramatically reversed by left bundle branch pacing in one week
por: Dandan Yang, MD, et al.
Publicado: (2021)

Seguimiento en fase aguda de catéteres electrodos de estimulación endocavitaria permanente: Comparación de tres modelos
por: Frangini S,Patricia, et al.
Publicado: (2006)

Cardiac resynchronization performed by LBBaP‐CRT in patients with cardiac insufficiency and left bundle branch block
por: Linna Zu, et al.
Publicado: (2021)

Magnetic Resonance Assessment of Ejection Fraction Versus Echocardiography for Cardioverter-Defibrillator Implantation Eligibility
por: Călin Schiau, et al.
Publicado: (2021)

Impaired Cardiac Sympathetic Innervation Increases the Risk of Cardiac Events in Heart Failure Patients with Left Ventricular Hypertrophy and Mechanical Dyssynchrony
por: Takahiro Doi, et al.
Publicado: (2021)

The Practice of Deep Sedation in Electrophysiology and Cardiac Pacing Laboratories: Results of an Italian Survey Promoted by the AIAC (Italian Association of Arrhythmology and Cardiac Pacing)
por: Pietro Palmisano, et al.
Publicado: (2021)

Reticular telangiectatic erythema: case report and literature review
por: Bryce D. Buetler, et al.
Publicado: (2015)

Management of Hypertrophic Cardiomyopathy
por: Alan D. Enriquez, et al.
Publicado: (2014)

Lead dislodgement after a very long‐term period of cardiac implantable electronic device implantation
por: Hidehiro Iwakawa, et al.
Publicado: (2021)

Continuous Electrical Monitoring in Patients with Arrhythmic Myocarditis: Insights from a Referral Center
por: Giovanni Peretto, et al.
Publicado: (2021)

Exercise test is essential in LV-only fusion CRT pacing without right ventricle lead
por: Vacarescu C, et al.
Publicado: (2019)

Can machine learning complement traditional medical device surveillance? A case-study of dual-chamber implantable cardioverter–defibrillators
por: Ross JS, et al.
Publicado: (2017)

Peripartum cardiomyopathy and cardiac resynchronization therapy: Case reports and literature review
por: Norman C. Wang, MD, MS, FHRS, et al.
Publicado: (2021)

Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the <styled-content style="fixed-case">eCTO</styled-content>py‐in‐<styled-content style="fixed-case">ICD</styled-content> Study)
por: Ivo M. van Dongen, et al.
Publicado: (2018)

Prognostic Role of Myocardial Edema as Evidenced by Early Cardiac Magnetic Resonance in Survivors of Out‐of‐Hospital Cardiac Arrest: A Multicenter Study
por: Alessandro Zorzi, et al.
Publicado: (2021)

Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads
por: Jayanthi N. Koneru, et al.
Publicado: (2018)

Resilience, Cardiological Outcome, and Their Correlations With Anxious-Depressive Symptoms and Quality of Life in Patients With an Implantable Cardioverter Defibrillator
por: Celeste Isella, et al.
Publicado: (2021)

Supervivencia a 30 días y 1 año de pacientes con muerte súbita con posterior colocación de dispositivo cardíaco implantable en un hospital de alta complejidad
por: Carvajal,Sandra, et al.
Publicado: (2020)

TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT
por: Muhammad Asad, et al.
Publicado: (2020)

Main air pollutants and ventricular arrhythmias in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis
por: Hong-Jie Yang, et al.
Publicado: (2017)

Safety and feasibility of biventricular devices reuse in general and elderly population – a single-center retrospective cohort study
por: Şoşdean R, et al.
Publicado: (2015)

La disincronía cardíaca se correlaciona con el remodelado ventrícular izquierdo postinfarto agudo al miocardio
por: McNab,Paul, et al.
Publicado: (2009)

Long-Term Performance Comparison of Bipolar Active vs. Quadripolar Passive Fixation Leads in Cardiac Resynchronisation Therapy
por: Fabian Schiedat, et al.
Publicado: (2021)

Albumin-Bilirubin Score for Prediction of Outcomes in Heart Failure Patients Treated with Cardiac Resynchronization Therapy
por: Shinya Yamada, et al.
Publicado: (2021)

Pacing and clinical electrophysiology PACE.
Publicado: (1978)

Dilated Cardiomyopathy and Prone Position: An Anesthetic Challenge
por: Bhavna Hooda, et al.
Publicado: (2020)

Disfunción miocárdica en la sepsis
por: ANDRESEN,MAX, et al.
Publicado: (2010)